Home/Filings/4/0000908662-17-000056
4//SEC Filing

HealthCor Partners LP 4

Accession 0000908662-17-000056

CIK 0001528557other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:06 PM ET

Size

23.9 KB

Accession

0000908662-17-000056

Insider Transaction Report

Form 4
Period: 2017-02-28
Transactions
  • Purchase

    Common Stock

    2017-02-28$0.66/sh+7,557,436$5,000,00015,409,537 total(indirect: See Footnotes)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    17,090,941
  • Common Stock

    (indirect: See Footnotes)
    19,981,655
Transactions
  • Purchase

    Common Stock

    2017-02-28$0.66/sh+7,557,436$5,000,00015,409,537 total(indirect: See Footnotes)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    17,090,941
  • Common Stock

    (indirect: See Footnotes)
    19,981,655
Transactions
  • Purchase

    Common Stock

    2017-02-28$0.66/sh+7,557,436$5,000,00015,409,537 total(indirect: See Footnotes)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    19,981,655
  • Common Stock

    (indirect: See Footnotes)
    17,090,941
Transactions
  • Purchase

    Common Stock

    2017-02-28$0.66/sh+7,557,436$5,000,00015,409,537 total(indirect: See Footnotes)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    17,090,941
  • Common Stock

    (indirect: See Footnotes)
    19,981,655
Transactions
  • Purchase

    Common Stock

    2017-02-28$0.66/sh+7,557,436$5,000,00015,409,537 total(indirect: See Footnotes)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    17,090,941
  • Common Stock

    (indirect: See Footnotes)
    19,981,655
Transactions
  • Purchase

    Common Stock

    2017-02-28$0.66/sh+7,557,436$5,000,00015,409,537 total(indirect: See Footnotes)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    19,981,655
  • Common Stock

    (indirect: See Footnotes)
    17,090,941
Transactions
  • Purchase

    Common Stock

    2017-02-28$0.66/sh+7,557,436$5,000,00015,409,537 total(indirect: See Footnotes)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    17,090,941
  • Common Stock

    (indirect: See Footnotes)
    19,981,655
Transactions
  • Purchase

    Common Stock

    2017-02-28$0.66/sh+7,557,436$5,000,00015,409,537 total(indirect: See Footnotes)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    19,981,655
  • Common Stock

    (indirect: See Footnotes)
    17,090,941
Transactions
  • Purchase

    Common Stock

    2017-02-28$0.66/sh+7,557,436$5,000,00015,409,537 total(indirect: See Footnotes)
Holdings
  • Common Stock

    (indirect: See Footnotes)
    17,090,941
  • Common Stock

    (indirect: See Footnotes)
    19,981,655
Footnotes (4)
  • [F1]HealthCor Partners Fund II, L.P. ("HCPII Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HCPGP, the general partner of HCP2LP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein.
  • [F2]HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCP Fund may be deemed to be beneficially owned by HealthCor Partners L.P. ("HCPLP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCPLP. Each of HCPLP and HCPGP hereby disclaims any beneficial ownership of shares held by HCP Fund except to the extent of any pecuniary interest therein.
  • [F3]HealthCor Partners Management, L.P. ("HPMLP") serves as the investment manager to each of HCP Fund and HCPII Fund, and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner of HPMLP. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each reporting person disclaims beneficial ownership of shares held by HCP Fund or HCPII Fund except to the extent of any pecuniary interest therein. Mr. Lightcap has separately filed a Form 4.
  • [F4]HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by Hybrid Fund may be deemed to be beneficially owned by HealthCor Hybrid Offshore GP, LLC ("Offshore GP"), its general partner, and by HealthCor Group, LLC ("Group"), the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of shares held by Hybrid Fund except to the extent of any pecuniary interest therein.

Issuer

Corindus Vascular Robotics, Inc.

CIK 0001528557

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001519456

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:06 PM ET
Size
23.9 KB